Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
14 hedge funds and large institutions have $743K invested in Genetic Technologies Ltd. in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
18% less capital invested
Capital invested by funds: $910K → $743K (-$168K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$13.1K |
| 3 |
BA
Ballew Advisors
Jackson,
Mississippi
|
+$2.16K |
| 4 |
Jane Street
New York
|
+$863 |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$795 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$291K |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
-$5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.5K |
| 4 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$908 |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$659 |
GENE Hedge Fund Activity: Q3 2018 in Review
14 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2018, worth a combined $743K — down 18% from $910K a quarter earlier.
Fund positioning in GENE was balanced in Q3 2018: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $13.7K. The largest seller was Renaissance Technologies, cutting an estimated $291K.
- 14 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $743K of Genetic Technologies Ltd. stock for Q3 2018, down 18% quarter-over-quarter.
- 3 funds opened new Genetic Technologies Ltd. positions in Q3 2018 and 3 closed out, a net change of 0 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2018 was Susquehanna International Group, an estimated $13.7K added.
- The largest Genetic Technologies Ltd. seller in Q3 2018 was Renaissance Technologies, an estimated $291K sold.
Based on aggregated 13F filings for Q3 2018.